Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart

Journal of Clinical Investigation

Volumn 104, Issue 12, 1999, Pages 1703-1714

  Abel, E Dale ^a,e   Kaulbach, Helen C ^a   Tian, Rong ^b   Hopkins, James C A ^b   Duffy, John ^c   Doetschman, Thomas ^c   Minnemann, Timo ^a   Boers, Mary Ellen ^a   Hadro, Ed ^a   Oberste Berghaus, Corinna ^a   Quist, William ^d   Lowell, Bradford B ^a   Ingwall, Joanne S ^b   Kahn, Barbara B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER; INSULIN; LACTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION; GENE INACTIVATION; GENETIC RECOMBINATION; GLUCOSE TRANSPORT; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION;

EID: 0033393822     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7605     Document Type: Article

References (57)

1. Taegtmeyer, H. 1994. Energy metabolism of the heart: from basic concepts to clinical applications. Curr. Probl. Cardiol. 19:57-116.
2. Gertz, E.W., Wisneski, J.A., Stanley, W.C., and Neese, R.A. 1988. Myocardial substrate utilization during exercise in humans. Dual carbonlabeled carbohydrate isotope experiments. J. Clin. Invest. 82:2017-2025.
3. Seymour, A.M., Eldar, H., and Radda, G.K. 1990. Hyperthyroidism results in increased glycolytic capacity in the rat heart. A 3IP-NMR study. Biochim. Biophys. Acta. 1055:107-116.
4. Opie, L.H. 1990. Myocardial ischemia - metabolic pathways and implications of increased glycolysis. Cardiovasc. Drugs Ther. 4:777-790.
5. Owen, P., Dennis, S., and Opie, L.H. 1990. Glucose flux rate regulates onset of ischemic contracture in globally underperfused rat hearts. Circ. Res. 66:344-354.
6. Nascimben, L., et al. 1995. Rates of insulin-independent glucose entry and glycolysis are increased in hypertrophied hearts. Circulation. 92(Suppl. I):I-770. (Abstr.)
7. Weinberg, E.O., Thienelt, C.D., and Lorell, B.H. 1995. Pretranslational regulation of glucose transporter isoform expression in hearts with pressure-overload left ventricular hypertrophy. Circulation. 92 (Suppl. I):I-385. (Abstr.)
8. Manchester, J., Kong, X., Nerbonne, J., Lowry, O.H., and Lawrence, J.C., Jr. 1994. Glucose transport and phosphorylation in single cardiac myocytes: rate-limiting steps in glucose metabolism. Am. J. Physiol. 266:E326-E333.
9. Mueckler, M. 1990. Family of glucose transporter genes. Implications for glucose homeostasis and diabetes. Diabetes. 39:6-11.
10. Bell, G.I., et al. 1990. Molecular biology of mammalian glucose transporters. Diabetes Care. 13:198-208.
11. Slot, J.W., Geuzo, H.J., Gigengack, S., James, D.E., and Lienhard, G.E. 1991 Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat. Proc. Natl. Acad. Sci. USA 88:7815-7819.
12. Egert, S., Nguyen, N., Brosius, F.C., III, and Schwaiger, M. 1997. Effects of wortmannin on insulin- and ischemia-induced stimulation of GLUT4 translocation and FDG uptake in perfused rat hearts. Cardiovasc. Res. 35:283-293.
13. Russell, R.R., III. et al. 1998. Additive effects of hyperinsulinemia and ischemia on myocardial GLUT1 and GLUT4 translocation in vivo. Circulation. 98:2180-2186.
14. Young, L.H., et al. 1997. Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation. 95:415-422.
15. Sun, P., Nguyen, N., Degrado, T.R., Schwaiger, M., and Brosius, F.C. 1994. Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes. Circulation. 89:793-798.
16. Till, M., Kolter, T., and Eckel, J. 1997. Molecular mechanisms of contraction-induced translocation of GLUT4 in isolated cardiomyocytes. Am. J. Cardiol. 80:85A-89A.
17. Holman, G.D., et al. 1990. Cell surface labeling of glucose transporter isoform GLUT4 by bis-mannose photolabel. Correlation with stimulation of glucose transport in rat adipose cells by insulin and phorbol ester. J. Biol. Chem. 265:18172-18379.
18. Dudek, R.W., Dohm, G.L., Holman, G.D., Cushman, S.W., and Wilson, C.M. 1994. Glucose transporter localization in rat skeletal muscle. Autoradiographic study using ATB-[2-3H]BMPA photolabel. FEBS Lett. 339:205-208.
19. Kahn, B.B., Rossetti, L., Lodish, H.F., and Charron, M.J. 1991. Decreased in vivo glucose uptake but normal expression of GLUT1 and GLUT4 in skeletal muscle of diabetic rats. J. Clin. Invest. 87:2197-2206.
20. Kraegen, E.W., et al. 1993. Glucose transporters and in vivo glucose uptake in skeletal and cardiac muscle: fasting, insulin stimulation and immunoisolation studies of GLUT1 and GLUT4. Biochem. J. 295:287-293.
21. Laybutt, D.R., Thompson, A.L., Cooney, G.J., and Kraegen, E.W. 1997. Selective chronic regulation of GLUT1 and GLUT4 content by insulin, glucose, and lipid in rat cardiac muscle in vivo. Am. J. Physiol. 273:H1309-H1316.
22. Burcelin, R., et al. 1993. Regulation of glucose transporter and hexokinase II expression in tissues of diabetic rats. Am. J. Physiol. 265:E392-E401.
23. vy/a). Diabetes. 41:187-193.
24. Kainulainen, H., et al. 1994. In vivo glucose uptake and glucose transporter proteins GLUT1 and GLUT4 in heart and various types of skeletal muscle from streptoxotocin-diabetic rats. Biochim. Biophys. Acta. 1225:275-282.
25. Garvey, W.T., Hardin, D., Juhaszova, M., and Dominguez, J.H. 1993. Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy. Am. J. Physiol. 264:H837-H844.
26. Paternostro, G., Clarke, K., Heath, J., Seymour, A.M., and Radda, G.K. 1995. Decreased GLUT-4 mRNA content and insulin-sensitive deoxyglucose uptake show insulin resistance in the hypertensive rat heart. Cardiovasc. Res. 30:205-211.
27. Montessuit, C., and Thorburn, A. 1999. Transcriptional activation of the glucose transporter GLUT1 in ventricular cardiac myocytes by hypertrophic agonists. J. Biol. Chem. 274:9006-9012.
28. Brosius, F.C., III, et al. 1997. Persistent myocardial ischemia increases GLUT1 glucose transporter expression in both ischemic and nonischemic heart regions. J. Mol. Cell. Cardiol. 29:1675-1685.
29. Katz, E.B., Stenbit, A.E., Hatton, K., Depinho, R., and Charron, M.J. 1995. Cardiac and adipose tissue abnormalities but nor diabetes in mice deficient in GLUT4. Nature. 377:151-155.
30. Stenbit, A.E., et al. 1997. GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat. Med. 3:1096-1101.
31. Tsao, T.S., et al. 1999. Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle. Diabetes. 48:775-782.
32. Rajewsky, K., et al. 1996. Conditional gene targeting. J. Clin. Invest. 98:600-603.
33. Li, E., Bestor, T.H., and Jaenisch, R. 1992. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell. 69:915-926.
34. Papaioannou, V., and Johnson, R. 1993. Production of chimeras and genetically defined offspring from targeted ES cells. In Gene targeting: a practical approach. A.L. Joyner, editor. Oxford University Press, Oxrord, United Kingdom. 107-146.
35. Subramaniam, A., et al. 1991. Tissue-specific regulation of the alphamyosin heavy chain gene promoter in transgenic mice. J. Biol. Chem. 266:24613-24620.
36. Frevert, E.U., and Kahn, B.B. 1996. Protein kinase C isoforms ε, η, δ, and ζ, in murine adipocytes expression, subcellular localization and tissue-specific regulation in insulin-resistant states. Biochem. J. 316:865-871.
37. Armstrong, A.T., Binkley, P.F., Baker, P.B., Myerowitz, P.D., and Leier, C.V. 1998. Quantitative investigation of cardiomyocyte hypertrophy and myocardial fibrosis over 6 years after cardiac transplantation. J. Am. Coll. Cardiol. 32:704-710.
38. Chien, K.R., Knowlton, K.U., Zhu, H., and Chien, S. 1991. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J. 5:3037-3046.
39. Fujiwara, H., and Nishigaki, K. 1998. Brain natriuretic peptide in hypertrophic obstructive cardiomyopathy. Cardiologia. 43:901-908.
40. Kaplan, M.L. et al. 1994. Cardiac adaptations to chronic exercise in mice. Am. J. Physiol. 267:H1167-H1173.
41. Hickson, R.C., Hammons, G.T., and Holoszy, J.O. 1979. Development and regression of exercise-induced cardiac hypertrophy in rats. Am. J. Physiol. 236:H268-H272.
42. Buttrick, P.M., Kaplan, M., Leinwand, L.A., and Scheuer, J. 1994. Alterations in gene expression in the rat heart after chronic pathological and physiological loads. J. Mol. Cell. Cardiol. 26:61-67.
43. Factor, S.M., Minase, T., and Sonnenblick, E.H. 1980. Clinical and morphological features of human hypertensive-diabetic cardiomyopathy. Am. Heart J. 99:446-458.
44. Sagnella, G.A. 1998. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin. Sci. (Colch.) 95:519-529.
45. Tian, R., Pham, M., and Abel, E.D. 1999. Cardiac glucose transporter deficiency increases the susceptibility of the heart to ischemic injury. Diabetes. 48 (Suppl. 1):A127. (Abstr.)
46. Tian, R., Pham, M., and Abel, E.D. 1999. Cardiac selective GLUT4 ablation exacerbates ATP depletion and contractile dysfunction during low flow ischemia. Circulation. 100(Suppl. I):I-344. (Abstr.)
47. Hampton, T., Wang, J.-F., Deangelis, J., and Abel. E.D. 1999. Preserved basal contractility but impaired responses to isoproterenol in vivo in mice with cardiac selective GLUT4 ablation. Circulation. 100(Suppl. I):I-118. (Abstr.)
48. Bogoyevitch, M.A., et al. 1994. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy. J. Biol. Chem. 269:1110-1119.
49. Sadoshima, J., and Izumo, S. 1993. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J. 12:1681-1692.
50. Bogoyevitch, M.A., et al. 1996. Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. Biochem. J. 314:115-121.
51. Sugden, P.H., and Clerk, A. 1998. "Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ. Res. 83:345-352.
52. Fischer, Y., et al. 1997. Insulin-induced recruitment of glucose transporter 4 (GLUT4) and GLT1 in isolated rat cardiac myocytes. Evidence of the existence of different intracellular GLUT4 vesicle populations. J. Biol. Chem. 272:7085-7092.
53. Clarke, J.E., Young, P.W., Yonezawa, K., Kasuga, M., and Holman, G.D. 1994. Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. Biochem. J. 300:631-635.
54. Laidlaw, J.S., Jelicks, L.A., and Charton, M.J. 1999. Metabolically altered and hypertrophied GLUT4-null hearts resist loss of function following ischemia/reperfusion. Diabetes. 48 (Suppl. 1):A75. (Abstr.)
55. Weiss, R.G., et al. 1998. In vivo cardiac energetics in GLUT4-null mice. Circulation. 98(Suppl. I):I-627. (Abstr.)
56. Bressler, R., and Goldman, S. 1993. A role of fatty acid oxidation in cardiac hypertrophy. Cardioscience. 4:133-142.
57. Holmang, A., Yoshida, N., Jennische, E., Waldenstrom, A., and Bjorntorp, P. 1996. The effects of hyperinsulinaemia on myocardial mass, blood pressure regulation and central haemodynamics in rats. Eur. J. Clin. Invest. 26:973-978.